UMF Group Inc. (UMFG) Stock Analysis
DELISTED 2024
What happened to UMF Group Inc. (UMFG) stock?
UMF Group Inc. (UMFG) no longer trades on public markets. It was delisted in March 2024. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
UMF Group Inc. (UMFG) trades at $0.0055. UMF Group Inc. focuses on developing whole plant extractions for cancer and palliative treatments within the medical marijuana sector. The company, formerly American Community Development Inc. Sector: Financial services.
Last analyzed: Mar 17, 2026Analyst Coverage for UMFG: UMFG does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates UMFG against Financial Services peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
UMF Group Inc. (UMFG) Financial Services Profile
UMF Group Inc., operating in the financial services sector, specializes in medical marijuana whole plant extraction for cancer and palliative treatments. Founded in 1988 and rebranded in 2017, the company faces challenges typical of OTC-listed firms in a competitive and evolving regulatory landscape.
What Is the Investment Thesis for UMFG?
UMF Group Inc. presents a speculative investment opportunity within the high-growth medical marijuana sector. The company's focus on whole plant extractions for cancer and palliative treatments aligns with increasing demand for alternative therapies. However, the company's OTC listing, minimal market capitalization ($0.00B), and negative P/E ratio (-54.27) indicate substantial risk. Growth catalysts include potential breakthroughs in research and development, regulatory changes favoring cannabis, and successful commercialization of its products. Key risks include intense competition, regulatory hurdles, and the company's limited financial resources. Investors should carefully consider these factors before investing in UMFG.
Based on FMP financials and quantitative analysis
UMFG Key Highlights
Market capitalization of $0.00B indicates a micro-cap company with limited assets and high volatility.
- Negative P/E ratio of -54.27 suggests the company is currently unprofitable.
- Beta of 6.82 indicates extremely high volatility compared to the overall market.
- Focus on whole plant extractions for cancer and palliative treatments positions the company in a niche market within the medical marijuana sector.
- Rebranding in 2017 signals a strategic shift towards the medical marijuana industry.
Who Are UMFG's Competitors?
UMFG is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| WDBG Woodbrook Group Holdings Inc. | $0.50 | +0.00% | 57 | |
| FDCT FDCTech, Inc. | $3.08 | -11.75% | $13.0M | 61 |
| CBTTF Cathedra Bitcoin Inc. | $0.46 | +25.16% | $13.4M | 56 |
| BBKCF BIGG Digital Assets Inc. | $0.05 | -6.09% | $16.5M | 62 |
| GSIW Garden Stage Limited provides financial services in Hong Kong, including securities dealing and brokerage, underwriting and placing, and asset management. The company | $16.80 | -0.74% | $23.7M | 61 |
| PLUT Plutus Financial Group Limited | $2.64 | -2.94% | $40.5M | 53 |
| STGC StartEngine Crowdfunding, Inc. | $0.15 | -94.83% | $113M | 61 |
| GEVI General Enterprise Ventures, Inc. | $9.08 | +8.61% | $159M | 56 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are UMFG's Key Strengths?
Focus on whole plant extractions.
- Specialization in cancer and palliative treatments.
- Rebranding reflects a clear strategic direction.
- Located in Colorado, a state with established cannabis regulations.
What Are UMFG's Weaknesses?
Small size and limited resources.
- OTC listing indicates higher risk and lower liquidity.
- Negative P/E ratio reflects current unprofitability.
- High beta indicates significant volatility.
What Could Drive UMFG Stock Higher?
Potential regulatory changes favoring cannabis could expand market opportunities.
- Successful clinical trials demonstrating the efficacy of whole plant extractions could drive demand.
- Increasing acceptance of medical marijuana for cancer and palliative treatments.
- Strategic partnerships with established healthcare providers could enhance distribution.
- Development of new and innovative cannabis-based products.
What Are the Key Risks for UMFG?
Intense competition in the cannabis industry could erode market share.
- Changes in federal cannabis policy could negatively impact the company's operations.
- Limited access to capital may hinder growth initiatives.
- Complex and evolving regulatory landscape increases compliance costs.
- Low liquidity and high volatility associated with OTC listing.
What Are the Growth Opportunities for UMFG?
- Expansion into new markets: As cannabis regulations evolve, UMF Group Inc. has the opportunity to expand its operations into new states and countries. The global medical cannabis market is projected to reach $55 billion by 2026, offering significant growth potential. Successful market entry requires navigating complex regulatory frameworks and establishing strategic partnerships.
- Development of new products: UMF Group Inc. can drive growth by developing new and innovative cannabis-based products targeting specific medical conditions. Investing in research and development to create proprietary formulations could provide a competitive advantage. The market for specialized cannabis products is expected to grow rapidly, driven by increasing demand for personalized medicine.
- Strategic partnerships: Collaborating with established pharmaceutical companies or healthcare providers can accelerate UMF Group Inc.'s growth. Partnerships can provide access to capital, distribution networks, and regulatory expertise. Strategic alliances can also enhance the company's credibility and market reach, fostering greater adoption of its products.
- Increased research and development: Investing further in research and development to validate the efficacy of whole plant extractions for cancer and palliative treatments can significantly enhance UMF Group Inc.'s market position. Positive clinical trial results could lead to increased acceptance by healthcare professionals and patients, driving demand for the company's products.
- Lobbying and advocacy: Actively participating in lobbying efforts to influence cannabis regulations can create a more favorable operating environment for UMF Group Inc. Advocating for policies that support medical cannabis research and access can help to expand the market and reduce regulatory barriers. Successful lobbying efforts can lead to increased market opportunities and reduced compliance costs.
What Are UMFG's Competitive Advantages?
- Proprietary extraction methods.
- Focus on a specific niche within the medical marijuana market.
- Early mover advantage in the whole plant extraction segment.
- Relationships with healthcare providers.
What Does UMFG Do?
UMF Group Inc., formerly known as American Community Development Inc., was founded in 1988 and rebranded in February 2017 to reflect its focus on the medical marijuana industry. Based in Boulder, Colorado, UMF Group Inc. is dedicated to the development of whole plant extractions, specifically targeting cancer and palliative treatments. The company's operations are centered around research and development in the cannabis sector, aiming to create innovative medical solutions. UMF Group's strategy involves leveraging the therapeutic properties of cannabis to address unmet needs in cancer care and palliative medicine. While the company is relatively small, with only four employees, it seeks to establish a presence in the burgeoning medical marijuana market. The company's evolution from American Community Development Inc. to UMF Group Inc. signifies a strategic shift towards a specialized area within the healthcare sector. UMF Group Inc. operates in a highly regulated environment, navigating the complexities of state and federal laws governing the cannabis industry. The company's success hinges on its ability to innovate, secure necessary approvals, and effectively market its products to healthcare providers and patients. The company's small size and OTC listing present both challenges and opportunities as it seeks to grow and establish itself in the competitive medical marijuana market.
What Products and Services Does UMFG Offer?
- Develop whole plant extractions for medical use.
- Focus on treatments for cancer and palliative care.
- Conduct research and development in the cannabis sector.
- Operate in the medical marijuana industry.
- Formulate cannabis-based products.
- Navigate complex regulatory frameworks.
How Does UMFG Make Money?
- Develops and patents whole plant extraction methods.
- Seeks regulatory approvals for medical cannabis products.
- Partners with healthcare providers for distribution.
- Generates revenue through product sales.
What Industry Does UMFG Operate In?
UMF Group Inc. operates within the rapidly evolving medical marijuana industry, which is experiencing significant growth due to increasing acceptance of cannabis for therapeutic purposes. The market is characterized by intense competition, with numerous companies vying for market share. Regulatory hurdles and varying state laws create additional challenges. UMF Group Inc.'s focus on whole plant extractions for cancer and palliative treatments positions it within a specialized segment of this market. The company competes with other cannabis companies, including BTNY, CATI, CNGT, LMSMF, and NMOC, as well as pharmaceutical companies developing alternative therapies.
Who Are UMFG's Key Customers?
- Patients seeking alternative cancer treatments.
- Healthcare providers specializing in palliative care.
- Medical marijuana dispensaries.
- Research institutions studying cannabis therapies.
Key Financial Metrics
Return on equity for UMF Group Inc. stands at 0.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -10.6%, showing how much profit it generates from its asset base. Its free cash flow yield is -18.8%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.01 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -167.0%, the inverse of the P/E and a quick read on earnings relative to price.
Company Profile
UMF Group Inc. operates in the Financial - Capital Markets industry within the Financial Services sector. It is headquartered in Boulder, US. The company is led by CEO Bruce A. Thompson. UMFG has traded publicly since 2011.
UMFG Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in UMF Group's future prospects, indicating that executives believe the stock is undervalued.
- Community sentiment has shifted positively, with discussions highlighting the company's innovative projects and their potential impact on growth.
- Analysts have noted improvements in operational efficiency, which could lead to better margins and profitability in the near term.
- The overall market outlook for the sector remains optimistic, with increasing demand for the services UMF Group provides.
Bear Case
- Concerns about the company's ability to scale operations effectively have been voiced within the community, leading to some skepticism.
- Recent news of regulatory scrutiny could pose challenges for UMF Group, creating uncertainty among investors.
- Negative sentiment has been fueled by competitors gaining market share, raising questions about UMF Group's competitive positioning.
- Insider selling activity was also reported, which may signal a lack of confidence among some executives regarding the company's short-term outlook.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
UMFG Latest News
No recent news available for UMFG.
Leadership: Bruce A. Thompson
Managing Director
Bruce A. Thompson serves as the managing director of UMF Group Inc., overseeing the company's strategic direction and operations. With a background in business management and a focus on emerging markets, Thompson has been instrumental in guiding UMF Group Inc.'s transition into the medical marijuana sector. His expertise includes corporate restructuring, market analysis, and regulatory compliance. He manages a small team of four employees, focusing on research and development of whole plant extractions.
Track Record: Since taking the helm, Thompson has led the rebranding effort and steered the company towards its current focus on cancer and palliative treatments. Key milestones include securing initial research partnerships and navigating the complex regulatory landscape. His leadership has been crucial in positioning UMF Group Inc. for future growth in the evolving medical marijuana market, despite the challenges of operating as an OTC-listed company.
UMFG OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, characterized by companies that may not meet minimum financial standards or reporting requirements. Unlike NYSE or NASDAQ-listed companies, firms in the OTC Other tier often have limited financial disclosure and may not be subject to the same level of regulatory scrutiny. This tier typically includes companies with limited operating history, distressed financials, or those that choose not to comply with higher listing standards, resulting in increased risk for investors.
- OTC Tier: OTC Other
- Limited financial disclosure increases the risk of investing in UMFG.
- Low liquidity can lead to significant price volatility.
- OTC Other tier status indicates a higher risk of fraud or mismanagement.
- Regulatory uncertainty surrounding the cannabis industry poses a threat to the company's operations.
- Small market capitalization makes the company vulnerable to market manipulation.
- Verify the company's legal standing and registration.
- Investigate the background and experience of the management team.
- Assess the company's financial condition and review any available financial statements.
- Research the company's business model and competitive landscape.
- Understand the regulatory environment in which the company operates.
- Evaluate the company's intellectual property and proprietary technology.
- Consult with a qualified financial advisor before investing.
- Focus on a specific niche within the medical marijuana market.
- Rebranding reflects a clear strategic direction.
- Located in Colorado, a state with established cannabis regulations.
- Management team with experience in business management.
What Investors Ask About UMF Group Inc. (UMFG) — Financial Services
What happened to UMF Group Inc. (UMFG) stock?
UMF Group Inc. (UMFG) no longer trades on public markets. It was delisted in March 2024. The figures below are historical and are not a current quote.
Can I still buy UMFG shares?
No. UMFG stopped trading on public markets in March 2024, so the shares are not available through a broker. Anything you see quoted for UMFG elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before UMFG stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to UMF Group Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does UMF Group Inc. do?
UMF Group Inc. is a medical marijuana company focused on developing whole plant extractions for cancer and palliative treatments. Operating in the financial services sector, the company researches and formulates cannabis-based products aimed at providing alternative therapies for patients. Formerly known as American Community Development Inc., UMF Group Inc.
What do analysts say about UMFG stock?
Currently, there is no available analyst coverage for UMFG stock due to its OTC listing and small market capitalization. Key valuation metrics such as P/E ratio (-54.27) indicate the company is currently unprofitable. Potential growth considerations include successful product development, regulatory changes, and strategic partnerships. Investors should conduct their own thorough due diligence, considering the inherent risks associated with micro-cap OTC stocks before making any investment decisions.
What are the main risks for UMFG?
UMFG faces several significant risks, including intense competition in the cannabis industry, complex and evolving regulatory challenges, and limited access to capital. As an OTC-listed company, UMFG is subject to lower liquidity and higher volatility, increasing the potential for significant price swings. The company's small size and limited resources also make it vulnerable to market manipulation and economic downturns.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available company data and may be limited due to the company's OTC listing and limited disclosure.
- AI analysis is pending and may provide further insights.